Carlos Jiménez‐Cortegana

1.1k total citations · 1 hit paper
38 papers, 669 citations indexed

About

Carlos Jiménez‐Cortegana is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Carlos Jiménez‐Cortegana has authored 38 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 16 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Carlos Jiménez‐Cortegana's work include Immune cells in cancer (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Immune Cell Function and Interaction (6 papers). Carlos Jiménez‐Cortegana is often cited by papers focused on Immune cells in cancer (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Immune Cell Function and Interaction (6 papers). Carlos Jiménez‐Cortegana collaborates with scholars based in Spain, United States and Israel. Carlos Jiménez‐Cortegana's co-authors include Víctor Sánchez‐Margalet, Antonio Pérez‐Pérez, Gonzalo Álba, Lorenzo Galluzzi, Luis de la Cruz‐Merino, Stina L. Wickström, Le Tong, Andreas Lundqvist, Claudia Galassi and Soledad López and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The Lancet Oncology.

In The Last Decade

Carlos Jiménez‐Cortegana

34 papers receiving 657 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin

2022 118 citations Antonio Pérez‐Pérez, Carlos Jiménez‐Cortegana et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos Jiménez‐Cortegana Spain	14	239	207	150	144	129	38	669
Alexandra Kitz United States	10	376 1.6×	150 0.7×	58 0.4×	114 0.8×	126 1.0×	12	748
Pippa F. Cosper United States	15	60 0.3×	127 0.6×	147 1.0×	173 1.2×	286 2.2×	26	699
Elisa Einwallner Austria	13	108 0.5×	53 0.3×	108 0.7×	95 0.7×	214 1.7×	22	582
P. Parini Sweden	9	130 0.5×	76 0.4×	236 1.6×	315 2.2×	202 1.6×	14	816
Sumbul Fatma United States	11	98 0.4×	65 0.3×	126 0.8×	89 0.6×	196 1.5×	14	562
Ayaz Ghani United States	7	213 0.9×	80 0.4×	74 0.5×	164 1.1×	350 2.7×	8	834
Nicole Hamers Netherlands	14	179 0.7×	52 0.3×	221 1.5×	191 1.3×	308 2.4×	18	674
Renata Talar‐Wojnarowska Poland	16	79 0.3×	358 1.7×	53 0.4×	160 1.1×	180 1.4×	75	739
Naziba Islam United States	13	147 0.6×	59 0.3×	116 0.8×	66 0.5×	168 1.3×	16	890

Countries citing papers authored by Carlos Jiménez‐Cortegana

Since Specialization

Citations

This map shows the geographic impact of Carlos Jiménez‐Cortegana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Jiménez‐Cortegana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Jiménez‐Cortegana more than expected).

Fields of papers citing papers by Carlos Jiménez‐Cortegana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Jiménez‐Cortegana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Jiménez‐Cortegana. The network helps show where Carlos Jiménez‐Cortegana may publish in the future.

Co-authorship network of co-authors of Carlos Jiménez‐Cortegana

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Jiménez‐Cortegana. A scholar is included among the top collaborators of Carlos Jiménez‐Cortegana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Jiménez‐Cortegana. Carlos Jiménez‐Cortegana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marhold, Maximilian, Marta Vaz Batista, Isabel Blancas, et al.. (2025). TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases. Future Oncology. 21(9). 1065–1073. 2 indexed citations

Fuereder, Thorsten, J. Garde, Juan Garcia, et al.. (2025). Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial. The Lancet Oncology. 26(11). 1454–1466.

García-Domínguez, Daniel J., et al.. (2024). Flow cytometry analysis of myeloid derived suppressor cells using 6 color labeling. Methods in cell biology. 190. 1–10. 1 indexed citations

Jiménez‐Cortegana, Carlos, et al.. (2024). Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review. Current Issues in Molecular Biology. 46(9). 9286–9297. 2 indexed citations

Jiménez‐Cortegana, Carlos, Teresa Vilariño‐García, Antonio Pérez‐Pérez, et al.. (2024). Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review). International Journal of Oncology. 65(2). 4 indexed citations

Jiménez‐Cortegana, Carlos, Carmen Garnacho, Luis de la Cruz‐Merino, et al.. (2023). Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International Journal of Molecular Sciences. 24(6). 5208–5208. 11 indexed citations

Jiménez‐Cortegana, Carlos, Flora Sánchez-Jiménez, Antonio Pérez‐Pérez, et al.. (2023). Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization. Frontiers in Immunology. 14. 1266659–1266659. 1 indexed citations

Sánchez-Jiménez, Flora & Carlos Jiménez‐Cortegana. (2023). The obesity paradox. Medicina Clínica (English Edition). 161(8). 342–343.

Guadix, Pilar, Isabel Corrales-Gutiérrez, Teresa Vilariño‐García, et al.. (2023). Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin. Frontiers in Endocrinology. 14. 1172831–1172831. 19 indexed citations

10.

Jiménez‐Cortegana, Carlos, Vanessa Klapp, Norma Bloy, et al.. (2022). Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in cell biology. 172. 1–16. 1 indexed citations

11.

Pérez‐Pérez, Antonio, et al.. (2022). Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin. International Journal of Molecular Sciences. 23(9). 5202–5202. 118 indexed citations breakdown →

12.

Jiménez‐Cortegana, Carlos, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich, & Lorenzo Galluzzi. (2022). Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research. 10(5). 545–557. 48 indexed citations

13.

Tong, Le, et al.. (2022). NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular Cancer. 21(1). 206–206. 108 indexed citations

14.

García-Domínguez, Daniel J., et al.. (2022). Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics. Cancers. 14(6). 1469–1469. 18 indexed citations

15.

Jiménez‐Cortegana, Carlos, et al.. (2022). The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells. Frontiers in Immunology. 13. 1050484–1050484. 20 indexed citations

16.

Jiménez‐Cortegana, Carlos, Jesús Sojo-Dorado, Luis de la Cruz‐Merino, et al.. (2021). Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19. Viral Immunology. 34(9). 639–645. 17 indexed citations

17.

Jiménez‐Cortegana, Carlos, Ana López-Saavedra, Flora Sánchez-Jiménez, et al.. (2021). Leptin, Both Bad and Good Actor in Cancer. Biomolecules. 11(6). 913–913. 41 indexed citations

18.

Jiménez‐Cortegana, Carlos, et al.. (2021). Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines. 9(7). 762–762. 70 indexed citations

19.

Sánchez‐Margalet, Víctor, et al.. (2019). Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy. Translational Cancer Research. 8(1). 59–65. 4 indexed citations

20.

Sánchez‐Margalet, Víctor, Teresa Vilariño‐García, Carlos Jiménez‐Cortegana, et al.. (2019). Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy. Translational Cancer Research. 8(1). 59–65. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact